Does clinical genetics perform hereditary cancer panel testing?

A hereditary cancer panel examines multiple genes associated with inherited cancer predisposition. The clinical genetics team chooses a panel that fits the cancers and ages at diagnosis in your personal and family history. Testing more genes can identify a relevant inherited change, but it may also return a variant whose health meaning is not yet clear. Pre-test counselling helps you consider these possible outcomes before providing a blood or saliva sample.

Prepare a family history covering both parental sides, with cancer types and ages at diagnosis wherever possible. Bring pathology details, previous tumour-testing reports, and any relative's genetic report that you can access. Ask which genes are included and why they match your history. Before consenting, make sure you understand the possible result categories, whether additional testing might follow, and how a finding may be communicated to biological relatives.

A clinical genetics assessment may be appropriate when several relatives have related cancers, cancer developed at an unexpectedly young age, a person has had multiple primary cancers, or family features do not point to only one gene. If you are in active cancer care, tell your oncology team when an inherited result might influence a treatment or surgical decision. For acute or worsening illness, use urgent medical care because genetic testing does not assess immediate symptoms.

Find out why a panel is preferred over a single-gene test, what an uncertain result would mean for current care, and whether an affected relative would be the most informative person to test first. Ask who will explain the report, which findings warrant follow-up, and what pathway is available if relatives want advice based on your result.